Author

Anatol Sucher

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Research Focus:protein structure prediction· 1 Organism:rat· 1

Frequent Co-Authors

Kord M. KoberiD· 2 shared Adam B. OlsheniD· 1 shared Dionéia AraldiiD· 1 shared Esther Chavez-IglesiasiD· 1 shared Jon D. LevineiD· 1 shared Julia TrudeauiD· 1 shared Marina SirotaiD· 1 shared Nam Woo ChoiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Kord M. KoberORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Alternative Splicing And Global Transcriptome Changes Associated With LPS Stimulation In Human Peripheral Blood Mononuclear Cells

Esther Chavez-Iglesias, Anatol Sucher, Nidhi Thati, Julia Trudeau, Sue Sun Yom, Marina Sirota, Adam B. Olshen, Nam Woo Cho, Kord M. Kober

This study examines alternative splicing and transcriptome changes in human PBMCs after LPS stimulation, identifying novel pathways and splicing events involved in inflammation.

bioRxiv · Nov 9, 2025 · PreprintImmunology

Isolectin B4 (IB4)-conjugated streptavidin for the selective knockdown of proteins in IB4-positive (+) nociceptors

Oliver Bogen, Dionéia Araldi, Anatol Sucher, Kord M. Kober, Peter T. Ohara, Jon D. Levine

This paper demonstrates that IB4-conjugated streptavidin can selectively knock down PKCε in IB4+ nociceptors, reversing hyperalgesic priming in a chronic pain model.

Molecular Pain · Jan 1, 2024Peer-reviewedNeuroscience